France: an attractive European Consumer Health and Pharma market
France’s Consumer Health and Pharma market is really mature but is still one of the strongest in the world. Yet, this market has potential and can bring new opportunities that can support your international expansion.
Situated in Western Europe and with several overseas regions and territories, France is one of the strongest economies and supporters in Europe. With a combined OTC and Pharma market value of 35 billion USD in 2020, France is certainly a mature market. In 2020, France ranked 8th in the Global country ranking, supporting the idea of a mature market. The French consumer health and prescription drug market should be worth USD 50 Billion ex-factory in 2035, according to our forecast.
French citizens spent on average 488€ in 2018 on medicines. The pharmacy density in France is 3214 inhabitants per pharmacy in 2022. Governmental support has allowed France to remain an attractive player in the pharmaceutical sector—and an attractive location for Pharma companies from all over the world.
If you are planning on entering France with your portfolio, our expertise and long-standing network can support you. The Chameleon Pharma Consulting Group has extensive OTC and pharma expertise in European markets, and we would be thrilled to support you to take advantage of the opportunities this region has to offer! We can support you with any questions regarding Regulatory topics, GMP Certificates, or Market Entry!
France OTC and pharma market in 2035
USD 49,93 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
France in numbers
Interested in this market?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.